CooperCompanies Announces Release Date for Third Quarter 2025
CooperCompanies (Nasdaq: COO), a leading medical device company, has scheduled its third quarter 2025 financial results announcement for August 27, 2025, at 4:15 PM ET.
The company will host a conference call at 5:00 PM ET to discuss results and corporate developments. Investors can join via phone at 800-715-9871 (Conference ID: 3665386) or access the audio webcast through the company's investor relations website.
CooperCompanies (Nasdaq: COO), un'azienda leader nel settore dei dispositivi medici, ha programmato l'annuncio dei risultati finanziari del terzo trimestre 2025 per il 27 agosto 2025, alle 16:15 ET.
L'azienda terrà una conference call alle 17:00 ET per discutere i risultati e gli sviluppi aziendali. Gli investitori potranno partecipare telefonicamente chiamando il 800-715-9871 (ID conferenza: 3665386) oppure seguire la trasmissione audio in streaming tramite il sito web delle relazioni con gli investitori della società.
CooperCompanies (Nasdaq: COO), una empresa líder en dispositivos médicos, ha programado el anuncio de sus resultados financieros del tercer trimestre de 2025 para el 27 de agosto de 2025, a las 4:15 PM ET.
La compañía realizará una llamada conferencia a las 5:00 PM ET para discutir los resultados y desarrollos corporativos. Los inversores pueden unirse por teléfono marcando el 800-715-9871 (ID de conferencia: 3665386) o acceder a la transmisión de audio a través del sitio web de relaciones con inversionistas de la empresa.
CooperCompanies (나스닥: COO)는 선도적인 의료기기 회사로서 2025년 3분기 재무 결과 발표를 2025년 8월 27일 오후 4시 15분 ET에 예정하고 있습니다.
회사는 결과 및 기업 동향에 대해 논의하기 위해 오후 5시 ET에 컨퍼런스 콜을 진행할 예정입니다. 투자자들은 전화 800-715-9871 (회의 ID: 3665386)로 참여하거나 회사 투자자 관계 웹사이트를 통해 오디오 웹캐스트를 청취할 수 있습니다.
CooperCompanies (Nasdaq : COO), une entreprise leader dans le domaine des dispositifs médicaux, a programmé l'annonce de ses résultats financiers du troisième trimestre 2025 pour le 27 août 2025 à 16h15 ET.
L'entreprise tiendra une conférence téléphonique à 17h00 ET pour discuter des résultats et des évolutions de l'entreprise. Les investisseurs peuvent participer par téléphone au 800-715-9871 (ID de conférence : 3665386) ou accéder à la diffusion audio en direct via le site web des relations investisseurs de la société.
CooperCompanies (Nasdaq: COO), ein führendes Medizintechnikunternehmen, hat die Bekanntgabe der Finanzergebnisse für das dritte Quartal 2025 für den 27. August 2025 um 16:15 Uhr ET geplant.
Das Unternehmen wird um 17:00 Uhr ET eine Telefonkonferenz abhalten, um die Ergebnisse und Unternehmensentwicklungen zu besprechen. Investoren können telefonisch unter 800-715-9871 (Konferenz-ID: 3665386) teilnehmen oder den Audiostream über die Investor-Relations-Webseite des Unternehmens verfolgen.
- None.
- None.
SAN RAMON, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report third quarter 2025 financial results on Wednesday, August 27, 2025, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.
The dial-in number for the call is 800-715-9871 and the conference ID is 3665386. A simultaneous audio webcast and subsequent replay can be accessed at http://investor.coopercos.com.
About CooperCompanies
CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life’s beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, helping to improve the way people see each day. CooperSurgical is a leading fertility and women’s healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies has a workforce of more than 16,000, sells products in over 130 countries, and positively impacts over fifty million lives each year. For more information, please visit www.coopercos.com.
Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com
FAQ
When will CooperCompanies (COO) report Q3 2025 earnings?
How can investors access CooperCompanies' Q3 2025 earnings call?
What time is CooperCompanies' (COO) Q3 2025 earnings conference call?
Where can I find the replay of CooperCompanies' Q3 2025 earnings call?
